Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-001801
Filing Date
2025-01-24
Accepted
2025-01-24 16:16:04
Documents
1
Period of Report
2025-01-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3196
  Complete submission text file 0001437749-25-001801.txt   4580
Mailing Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108
Business Address 24 SCHOOL ST., 2ND FLOOR BOSTON MA 02108 401-426-4664
Allarity Therapeutics, Inc. (Issuer) CIK: 0001860657 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 210 BROADWAY, STE 201 CAMBRIDGE MA 02139
Business Address
Jensen Thomas (Reporting) CIK: 0001888277 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41160 | Film No.: 25554413